ProMIS Neurosciences (PMN) Institutional Ownership $0.82 -0.09 (-9.45%) Closing price 02/21/2025 03:58 PM EasternExtended Trading$0.82 +0.01 (+1.23%) As of 02/21/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ProMIS Neurosciences (NASDAQ:PMN)CurrentInstitutional OwnershipPercentage50.13%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$4.48MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$214.85K Get PMN Insider Trade Alerts Want to know when executives and insiders are buying or selling ProMIS Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PMN Institutional Buying and Selling by Quarter ProMIS Neurosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Allostery Investments LP195,111$185K0.2%N/A0.597% 2/14/2025 Heights Capital Management Inc.160,207$152K0.1%-58.6%0.490% 11/15/2024 Sphera Funds Management LTD.1,929,297$2.41M0.4%+6.3%6.455% 11/14/2024 Ally Bridge Group NY LLC1,592,605$1.99M1.1%+50.3%5.328% 11/13/2024 Great Point Partners LLC2,790,698$3.49M1.0%N/A9.337% 2/7/2024 Ieq Capital LLC30,799$35K0.0%-21.4%0.163% 11/15/2023 Affinity Asset Advisors LLC265,958$527K0.1%N/A3.100% 11/15/2022 Northeast Financial Consultants Inc100,000$613K0.0%N/A1.166% 11/4/2022 Ieq Capital LLC39,191$240K0.0%N/A0.457% (Data available from 1/1/2016 forward) PMN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PMN shares? During the previous two years, the following institutional investors and hedge funds held shares of ProMIS Neurosciences shares: Great Point Partners LLC ($3.49M), Sphera Funds Management LTD. ($2.41M), Ally Bridge Group NY LLC ($1.99M), Affinity Asset Advisors LLC ($527K), Allostery Investments LP ($185K), and Heights Capital Management Inc. ($152K), and Ieq Capital LLC ($35K).Learn more on PMN's institutional investors. What percentage of ProMIS Neurosciences stock is owned by institutional investors? 50.13% of ProMIS Neurosciences stock is owned by institutional investors. Learn more on PMN's institutional investor holdings. Which institutional investors have been buying ProMIS Neurosciences stock? The following institutional investors have purchased ProMIS Neurosciences stock in the last 24 months: Great Point Partners LLC ($2.79M), Ally Bridge Group NY LLC ($533.02K), Affinity Asset Advisors LLC ($265.96K), Allostery Investments LP ($195.11K), and Sphera Funds Management LTD. ($115.08K). How much institutional buying is happening at ProMIS Neurosciences? Institutional investors have bought a total of 3,899,874 shares in the last 24 months. This purchase volume represents approximately $5.01M in transactions. Which ProMIS Neurosciences major shareholders have been selling company stock? The following institutional investors have sold ProMIS Neurosciences stock in the last 24 months: Heights Capital Management Inc. ($226.69K), and Ieq Capital LLC ($8.39K). How much institutional selling is happening at ProMIS Neurosciences? Institutional investors have sold a total of 235,079 shares in the last 24 months. This volume of shares sold represents approximately $224.50K in transactions. Related Companies Cardiol Therapeutics Major Shareholders Coya Therapeutics Major Shareholders Milestone Pharmaceuticals Major Shareholders Zura Bio Major Shareholders Cassava Sciences Major Shareholders Vigil Neuroscience Major Shareholders Eupraxia Pharmaceuticals Major Shareholders Invizyne Technologies Major Shareholders Editas Medicine Major Shareholders Procaps Group Major Shareholders This page (NASDAQ:PMN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
